Related Experiment Video

Updated: May 13, 2026

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids
05:39

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids

Published on: April 5, 2024

Polymorphisms in oxidative stress-related genes and mortality in breast cancer patients--potential differential

Petra Seibold1, Per Hall, Nils Schoof

  • 1Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Breast (Edinburgh, Scotland)
|March 16, 2013
PubMed

Keywords:
BCSSBreast cancer prognosisCATCICTxCYBAEREffect modificationGPX1GSRGSTA1GSTO1Genetic variantsHMOX1HRHSPB1HWEHardy–Weinberg equilibriumLDMAFMPOMT2AMnSODNAD(P)HNAD(P)H dehydrogenase quinone 1NFE2L2NOS3NQO1OSOxidative stressPRPRDXRTxRadiotherapySNPSOD1SOD2TNFTXNTXN2TXNRD1TXNRD2breast cancer-specific survivalcatalasechemotherapyconfidence intervalcytochrome b-245 alpha polypeptideglutathione S-transferase alpha 1glutathione S-transferase omegaglutathione peroxidase 1glutathione reductasehazard ratioheat shock 27 kDa protein 1heme oxygenase 1linkage disequilibriummanganase superoxide dismutase, see also SOD2metallothionein 2Aminor allele frequencymyeloperoxidasenicotinamide adenine dinucleotide phosphatenitric oxide synthase 3, endothelial nitric oxide synthasenuclear factor erythroid-derived 2-like 2oestrogen receptoroverall survivalperoxiredoxinprogesterone receptorradiotherapysingle nucleotide polymorphismsuperoxide dismutase 1superoxide dismutase 2, mitochondrial, see also MnSODthioredoxin 2, mitochondrialthioredoxin reductase 1, cytosolicthioredoxin reductase 2, mitochondrialthioredoxin, cytosolictumor necrosis factor

More Related Videos

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer05:30

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...